Clinical trial
PD-L1 Targeting Molecular Imaging of Solid Tumors
NCT04629326 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PD-L1 Targeting Molecular Imaging of Solid Tumors
- Lead sponsor
- Peking University Cancer Hospital & Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 20, 2021
- Completion date
- November 30, 2024
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal tumors